Pernix Therapeutics Says GlaxoSmithKline Claimed That Co Owes Damages Relating to Alleged Breach of Covenant Contained in Asset Purchase Agreement; Pernix Says Booked Reserve of $3.5M for 2014 for Legal Settlement Related the Matter